Mammary cancer gene therapy targeting lymphangiogenesis : VEGF-C siRNA and soluble VEGF receptor-2, a splicing variant
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-12-01
著者
-
HARADA SHIBA
Department of Bioscience, National Cardiovascular Center Research Institute
-
Yoshidome Katsuhide
Department Of Surgery Osaka Police Hospital
-
SHIBATA Masa-Aki
Laboratory of Anatomy and Histopathology, Faculty of Health Science, Osaka Health Science University
-
HARADA SHIBA
Department of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute
-
AMBATI Jayakrishna
Department of Ophthalmology and Visual Science and Physiology, University of Kentucky
-
SHIBATA Eiko
Department of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute
-
YOSHIDOME Katsuhide
Department of Breast Cancer and Endocrine Surgery, Graduate School of Medicine, Osaka University
-
SHIBATA Eiko
Department of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute
関連論文
- Long-Term Probucol Treatment Prevents Secondary Cardiovascular Events : a Cohort Study of Patients with Heterozygous Familial Hypercholesterolemia in Japan
- Multiple Benign Metastasizing Leiomyomas in the Pelvic Lymph Nodes and Biceps Muscle : Report of a Case
- Unresectable gastric cancer with multiple liver metastases effectively treated with combined paclitaxel and doxifluridine chemotherapy
- Pancreatoduodenectomy for melanoma with metastasis to the common bile duct
- Mammary cancer gene therapy targeting lymphangiogenesis : VEGF-C siRNA and soluble VEGF receptor-2, a splicing variant